Maastricht University Medical Centre-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2017

  1. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

2016

  1. Prognostic assessment in COPD without lung function: The B-AE-D indices

    European Respiratory Journal, Vol. 47, Núm. 6, pp. 1635-1644

2010

  1. Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda

    Experimental Dermatology

2009

  1. A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma

    British Journal of Dermatology, Vol. 160, Núm. 6, pp. 1330-1334

2007

  1. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: Characterization of 10 novel mutations in the UROD gene

    British Journal of Dermatology, Vol. 157, Núm. 3, pp. 501-507